Performance History
| Key Stats | |
|---|---|
| Open | $211.37 |
| Prev. Close | $216.16 |
| EPS | 6.51 |
| Dividend | $1.92 |
| Next Earnings Date | Sep 12, 2024 |
| Dividend Yield % | 0.89% |
| Market Cap | $31.78B |
| PE Ratio | 32.70 |
| LOW | HIGH | |
|---|---|---|
| Day Range | 210.39 | 212.92 |
| 52 Week Range | 132.24 | 237.25 |
| Ratios | |
|---|---|
| P/B Ratio | 6.10 |
| Revenue | $4.22B |
| Operating M. % | 31.29% |
| Earnings | $897.55M |
| Earnings Growth % | 15.15% |
| EBITDA Margin % | 34.13% |
| ROEÂ % | 22.39% |
| EPS | 6.51 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
All Score 79 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.
| RMD | MARKET | |
|---|---|---|
| Value | 36 | 37 |
| Quality | 87 | 40 |
| Ownership | 26 | 17 |
| Growth | 66 | 46 |
| Dividends | 29 | 37 |
ResMed 's Return on capital employed (ROCE) of 21.39% is great compared to market average of 8.34%. This indicates RMD could be an efficient company.
Financial Forecast
AI Price Prediction
Analyst Ratings
Correlated Companies
About ResMed (RMD)
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- CEO
- Mr. Michael J. Farrell BE, MBA, SM
- Headquarters
- San Diego
- Employees
- 8160
- Exchange
- NYSE
Keep an eye on ResMed
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
What is ResMed 's (RMD) price per share?
The current price per share for ResMed (RMD) is $212.88. The stock has seen a price change of -$3.28 recently, indicating a -1.52% change. This reflects the stock's recent market performance and investor sentiment.
What is the 52-week high and low for ResMed (RMD)?
For ResMed (RMD), the 52-week high is $237.26, which is 11.45% from the current price. The 52-week low is $132.24, the current price is 60.98% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
Is ResMed (RMD) a growth stock?
ResMed (RMD) has shown an average price growth of 0.41% over the past three years. It has received a score of 48 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying ResMed as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
What is ResMed (RMD) stock price performance year to date (YTD)?
As of the latest data, ResMed (RMD) has a year-to-date price change of 23.93%. Over the past month, the stock has experienced a price change of 13.38%. Over the last three months, the change has been 15.85%. Over the past six months, the figure is 43.08%. Looking at a longer horizon, the five-year price change stands at 91.06%.
Is ResMed (RMD) a profitable company?
ResMed (RMD) has a net income of $897.56M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 55.78% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 31.29% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $4.22B, with a revenue growth rate of 18.02%, providing insight into the company's sales performance and growth. The gross profit is $2.36B. Operating income is noted at $1.13B. Furthermore, the EBITDA is $1.56B.
What is the market capitalization of ResMed (RMD)?
ResMed (RMD) has a market capitalization of $31.79B. The average daily trading volume is 1.5M, indicating the stock's liquidity and investor engagement.
News
Traders Pile Up Short Positions as Grayscale Abandons Ethereum Futures ETF Plan
Global Smartphone Shipments Jump by 20 Million Units Year-over-Year in Q1 2024
Pixel 8a Unveiled: Google’s AI Revolution Goes Mainstream
Visa’s Quarterly Revenue Jumped by $800 Million YoY and Hit an All-Time High of $8.75 Billion
Samsung Overtakes Apple in Q1 2024 Mobile Phone Shipments with 20.8% Market Share
Financial Industry Plagued by Ransomware Attacks; 65% of Organizations Suffered Ransomware Damage in 2023
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.